+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Healthcare Contract Development & Manufacturing Organization Market (2020-2025) by services Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5304389
  • Report
  • February 2021
  • Region: Global
  • 181 pages
  • Infogence Marketing and Advisory Services
until Jul 31st 2021
The Global Healthcare Contract Development & Manufacturing Organization Market is Estimated to be USD 193 Bn in 2020 and is Expected to Reach USD 286 Bn by 2025, Growing at a CAGR of 8.2 %


  • AbbVie Inc.
  • B. Braun Melsungen AG
  • Covance Inc.
  • IQVIA Holdings Inc
  • Lonza Group Ltd.
  • Recipharm AB
  • MORE
The Global Healthcare Contract Development & Manufacturing Organization Market is estimated to be USD 193 Bn in 2020 and is expected to reach USD 286 Bn by 2025, growing at a CAGR of 8.2 %.

Market Dynamics
Key factors, such as the growing number of new molecular entities have led to a demand for high-end technical expertise. Also, at given times, to expedite the drug manufacturing process, pharma companies are depending on CDMOs for their niche technical expertise to get the product in the market. In addition to it, companies are equally focusing on reducing the capital expenditure involved in manufacturing processes. These factors are prominently driving the growth of the contract development and manufacturing organization (CDMO) market.

However, the serialization issues along with the infringement issues related to intellectual property are likely to restrain the market growth.

Market Segmentation

The Global Healthcare Contract Development & Manufacturing Organization Market is segmented further based on services and Geography.

By Services, the market is classified as contract development and contract manufacturing. Amongst the two, the contract manufacturing segment is estimated to hold the highest market share.

By Geography, North America is projected to lead the market.

Recent Developments
1. Moderna, Inc and Recipharm AB, a CDMO have drafted an agreement to support the formulation and fill-finish a part of the Moderna COVID-19 Vaccine supply outside the U.S. - 30th December 2020
2. Siegfried has acquired two pharmaceutical manufacturing sites from Novartis based out of Spain. This is in view towards creating a center of excellence for the sites’ current technology portfolio in the Barcelona region.- 29th September 2020

Company Profiles

Some of the companies covered in this report are Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Covance Inc.; Jabil; Sanmina Corporation; IQVIA Holdings Inc.; and Flex.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments and growth in market share.

Why buy this report?
  • The report offers a comprehensive evaluation of the Global Healthcare Contract Development & Manufacturing Organization Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size.
  • The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using Positioning Quadrants, the analyst's proprietary competitive positioning tool.

Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Note: Product cover images may vary from those shown


  • AbbVie Inc.
  • B. Braun Melsungen AG
  • Covance Inc.
  • IQVIA Holdings Inc
  • Lonza Group Ltd.
  • Recipharm AB
  • MORE
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary

4 Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers Need of a high-level expertise to expedite drug manufacturing process Focus of the pharmaceutical companies towards reducing their operational expenses Increasing complexity with the development of new molecular entities
4.2.2 Restraints Serialization issues faced by healthcare organizations Issues related to infringement of Intellectual Property (IP) rights
4.2.3 Opportunities Rise in the drug approvals cases Technological Advancements Increasing collaborations and investments by CDMOs
4.2.4 Challenges Compliance issues while outsourcing
4.3 Trends

5 Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6 Global Healthcare Contract Development & Manufacturing Organization Market, By Service
6.1 Introduction
6.2 Contract Development
6.2.1 Preclinical Bioanalysis and DMPK studies Toxicology Testing Other Preclinical Services
6.2.2 Clinical Phase I Phase II Phase III Phase IV
6.2.3 Laboratory Services Bioanalytical Services Analytical Services
6.3 Contract Manufacturing
6.3.1 API/Bulk Drugs
6.3.2 Finished Dose Formulations
6.3.3 Medical Device Class I Class II Class III

7 Global Healthcare Contract Development & Manufacturing Organization Market, By Solution Type
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 South America
7.3.1 Brazil
7.3.2 Argentina
7.4 Europe
7.4.1 UK
7.4.2 France
7.4.3 Germany
7.4.4 Italy
7.4.5 Spain
7.4.6 Rest of Europe
7.5 Asia-Pacific
7.5.1 China
7.5.2 Japan
7.5.3 India
7.5.4 Indonesia
7.5.5 Malaysia
7.5.6 South Korea
7.5.7 Australia
7.5.8 Russia
7.5.9 Rest of APAC
7.6 Rest of the World
7.6.1 Qatar
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 United Arab Emirates
7.6.5 Latin America

8 Competitive Landscape
8.1 IGR Competitive Quadrant
8.2 Market Share Analysis
8.3 Competitive Scenario
8.3.1 Mergers & Acquisitions
8.3.2 Agreement, Collaborations, & Partnerships
8.3.3 New Product Launches & Enhancements
8.3.4 Investments & Fundings

9 Company Profiles
9.1 AbbVie Inc.
9.2 Almac Group Ltd.
9.3 Baxter International, Inc.
9.4 B. Braun Melsungen AG
9.5 Boehringer Ingelheim International GmbH
9.6 Catalent Inc.
9.7 Covance Inc.
9.8 Cambrex Corp. (Permira Funds)
9.9 Hisun Pharmaceuticals Inc.
9.10 Jabil Inc.
9.11 Jubilant Life Sciences Ltd.
9.12 IQVIA Holdings Inc
9.13 Flex
9.14 Lonza Group Ltd.
9.15 Mikart LLC (Nautic Partners)
9.16 Pfizer Inc.
9.17 Probiogen AG (Minapharm Pharmaceuticals)
9.18 Recipharm AB
9.19 Siegfried Holding AG
9.20 Sanmina Corp.
9.21 Stason Pharmaceuticals, Inc.
9.22 Thermo Fisher Scientific Inc.

10 Appendix
10.1 Questionnaire
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Almac Group Ltd.
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.
  • Covance Inc.
  • Cambrex Corp. (Permira Funds)
  • Hisun Pharmaceuticals Inc.
  • Jabil Inc.
  • Jubilant Life Sciences Ltd.
  • IQVIA Holdings Inc
  • Flex
  • Lonza Group Ltd.
  • Mikart LLC (Nautic Partners)
  • Pfizer Inc.
  • Probiogen AG (Minapharm Pharmaceuticals)
  • Recipharm AB
  • Siegfried Holding AG
  • Sanmina Corp.
  • Stason Pharmaceuticals, Inc.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown